ETV5 links the FGFR3 and Hippo signalling pathways in bladder cancer

Activating mutations of fibroblast growth factor receptor 3 (FGFR3) are common in urothelial carcinoma of the bladder (UC). Silencing or inhibition of mutant FGFR3 in bladder cancer cell lines is associated with decreased malignant potential, confirming its important driver role in UC. However, unde...

Descripción completa

Detalles Bibliográficos
Autores principales: di Martino, Erica, Alder, Olivia, Hurst, Carolyn D., Knowles, Margaret A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450944/
https://www.ncbi.nlm.nih.gov/pubmed/30952872
http://dx.doi.org/10.1038/s41598-018-36456-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450944/
https://www.ncbi.nlm.nih.gov/pubmed/30952872
http://dx.doi.org/10.1038/s41598-018-36456-3

Ejemplares similares